Login / Signup
Yu Deng
ORCID
Publication Activity (10 Years)
Years Active: 2018-2020
Publications (10 Years): 4
Top Topics
Drug Delivery
Dna Damage Response
Endoplasmic Reticulum Stress
Binding Protein
Top Venues
Molecular carcinogenesis
Journal of breast cancer
Evidence-based complementary and alternative medicine : eCAM
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yu Deng
,
Wanjun Guo
,
Ning Xu
,
Fulun Li
,
Jian Li
CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Molecular carcinogenesis
59 (5) (2020)
Yu Deng
,
Wanjun Zhang
,
Guancheng Li
,
Shuang Li
,
Hong Li
,
Xin-Yan Li
,
Bei Niu
,
Mingzhu Song
,
Yamei Zhang
,
Zhijian Xu
,
Fu-Lun Li
Protocatechuic Aldehyde Represses Proliferation and Migration of Breast Cancer Cells through Targeting C-terminal Binding Protein 1.
Journal of breast cancer
23 (1) (2020)
Minfeng Wu
,
Yan Li
,
Dongjie Guo
,
Gang Kui
,
Bin Li
,
Yu Deng
,
Fu-Lun Li
Microbial Diversity of Chronic Wound and Successful Management of Traditional Chinese Medicine.
Evidence-based complementary and alternative medicine : eCAM
2018 (2018)
Yu Deng
,
Fulun Li
,
Pinglin He
,
Yafei Yang
,
Jin Yang
,
Yamei Zhang
,
Junying Liu
,
Yongping Tong
,
Qingfeng Li
,
Xian Mei
,
Zengyi Shu
,
Qi Zhao
Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition.
Molecular carcinogenesis
57 (6) (2018)